Page last updated: 2024-10-17

phloroglucinol and Acute Myelogenous Leukemia

phloroglucinol has been researched along with Acute Myelogenous Leukemia in 2 studies

Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.

Research Excerpts

ExcerptRelevanceReference
"Hyperforin is a prenylated phloroglucinol present in the medicinal plant St John's wort (Hypericum perforatum)."2.49Mechanistic insights into the antileukemic activity of hyperforin. ( Bauvois, B; Billard, C; Merhi, F, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merhi, F2
Tang, R1
Piedfer, M1
Mathieu, J1
Bombarda, I1
Zaher, M1
Kolb, JP1
Billard, C2
Bauvois, B2

Reviews

1 review available for phloroglucinol and Acute Myelogenous Leukemia

ArticleYear
Mechanistic insights into the antileukemic activity of hyperforin.
    Current cancer drug targets, 2013, Volume: 13, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B

2013

Other Studies

1 other study available for phloroglucinol and Acute Myelogenous Leukemia

ArticleYear
Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; Casp

2011